Further studies are needed to dissect the complexity of targets that are controlled by BACH1/Nrf2 signaling and the potential mechanisms that are relevant to aging and neurodegeneration not only in DS but also in AD and, potentially, in other neurodegenerative disorders. This evidence concerns the gene NFE2L2 and Dravet syndrome.